Related News
Home » Business » Manufacturing
Bayer ‘fully cooperating’ in inquiry
Print Edition
Chinese authorities investigated a possible case of unfair competition by the local office of Bayer AG which they visited in late August, the German drug maker said yesterday.
The investigation by the State Administration for Industry and Commerce, responsible for market supervision, showed that China is determined to crack down on corruption and other malpractices in its pharmaceutical industry.
In a statement, Bayer said it is “fully cooperating with the authority” but didn’t release more details.
Bayer, which also makes plastics and crop chemicals, reiterated the company doesn’t tolerate violations and takes appropriate action to ensure its Chinese subsidiary’s marketing and sales activities comply with laws and regulations.
“In case of allegations or non-observance of the Bayer Corporate Compliance Policy by employees, Bayer will investigate them thoroughly and take full responsibility for appropriate measures,” its statement said.
China has been investigating corruption and other illegal practices in the pharmaceutical industry as some drug makers were accused of bribing doctors and hospitals to prescribe drugs, driving up prices and costs for patients.
A number of foreign drug makers, including Eli Lilly of the US, France’s Sanofi and Belgian firm UCB have been investigated by Chinese authorities in the ongoing crackdown that began with British firm GlaxoSmithKline.
Chinese police have detained four Chinese executives of GSK over allegations they had set aside up to 3 billion yuan (US$490.2 million) to offer as bribes since 2007. GSK has also said some senior Chinese executives appear to have broken the law.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
